-
Je něco špatně v tomto záznamu ?
Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency
A. Klocperk, D. Friedmann, AE. Schlaak, S. Unger, Z. Parackova, S. Goldacker, A. Sediva, B. Bengsch, K. Warnatz
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01
Medline Complete (EBSCOhost)
od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01
Public Health Database (ProQuest)
od 1997-01-01
Springer Nature OA/Free Journals
od 1981-01-01
- MeSH
- antigeny CD279 genetika MeSH
- antigeny CD28 MeSH
- běžná variabilní imunodeficience * MeSH
- CD8-pozitivní T-lymfocyty MeSH
- HLA-DR antigeny MeSH
- interleukin-10 MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency, with heterogeneous clinical presentation. Our goal was to analyze CD8 T cell homeostasis in patients with infection only CVID, compared to those additionally affected by dysregulatory and autoimmune phenomena. METHODS: We used flow and mass cytometry evaluation of peripheral blood of 40 patients with CVID and 17 healthy donors. RESULTS: CD8 T cells are skewed in patients with CVID, with loss of naïve and increase of effector memory stages, expansion of cell clusters with high functional exhaustion scores, and a highly activated population of cells with immunoregulatory features, producing IL-10. These findings correlate to clinically widely used B cell-based EURO classification. Features of exhaustion, including loss of CD127 and CD28, and expression of TIGIT and PD-1 in CD8 T cells are strongly associated with interstitial lung disease and autoimmune cytopenias, whereas CD8 T cell activation with elevated HLA-DR and CD38 expression predict non-infectious diarrhea. CONCLUSION: We demonstrate features of advanced differentiation, exhaustion, activation, and immunoregulatory capabilities within CD8 T cells of CVID patients. Assessment of CD8 T cell phenotype may allow risk assessment of CVID patients and provide new insights into CVID pathogenesis, including a better understanding of mechanisms underlying T cell exhaustion and regulation.
Faculty of Biology University of Freiburg Freiburg Germany
German Cancer Consortium partner site Freiburg Freiburg Germany
Institute of Experimental Immunology University of Zurich Zurich Switzerland
Signaling Research Centres BIOSS and CIBSS University of Freiburg Freiburg Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033351
- 003
- CZ-PrNML
- 005
- 20230131151308.0
- 007
- ta
- 008
- 230120s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10875-022-01291-9 $2 doi
- 035 __
- $a (PubMed)35589883
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Klocperk, Adam $u Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. adam.klocperk@fnmotol.cz $u Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. adam.klocperk@fnmotol.cz $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic. adam.klocperk@fnmotol.cz $1 https://orcid.org/0000000215264557
- 245 10
- $a Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency / $c A. Klocperk, D. Friedmann, AE. Schlaak, S. Unger, Z. Parackova, S. Goldacker, A. Sediva, B. Bengsch, K. Warnatz
- 520 9_
- $a PURPOSE: Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency, with heterogeneous clinical presentation. Our goal was to analyze CD8 T cell homeostasis in patients with infection only CVID, compared to those additionally affected by dysregulatory and autoimmune phenomena. METHODS: We used flow and mass cytometry evaluation of peripheral blood of 40 patients with CVID and 17 healthy donors. RESULTS: CD8 T cells are skewed in patients with CVID, with loss of naïve and increase of effector memory stages, expansion of cell clusters with high functional exhaustion scores, and a highly activated population of cells with immunoregulatory features, producing IL-10. These findings correlate to clinically widely used B cell-based EURO classification. Features of exhaustion, including loss of CD127 and CD28, and expression of TIGIT and PD-1 in CD8 T cells are strongly associated with interstitial lung disease and autoimmune cytopenias, whereas CD8 T cell activation with elevated HLA-DR and CD38 expression predict non-infectious diarrhea. CONCLUSION: We demonstrate features of advanced differentiation, exhaustion, activation, and immunoregulatory capabilities within CD8 T cells of CVID patients. Assessment of CD8 T cell phenotype may allow risk assessment of CVID patients and provide new insights into CVID pathogenesis, including a better understanding of mechanisms underlying T cell exhaustion and regulation.
- 650 _2
- $a antigeny CD28 $7 D018106
- 650 _2
- $a CD8-pozitivní T-lymfocyty $7 D018414
- 650 12
- $a běžná variabilní imunodeficience $7 D017074
- 650 _2
- $a HLA-DR antigeny $7 D006684
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-10 $7 D016753
- 650 _2
- $a antigeny CD279 $x genetika $7 D061026
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Friedmann, David $u Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Faculty of Biology, University of Freiburg, Freiburg, Germany
- 700 1_
- $a Schlaak, Alexandra Emilia $u Clinic for Internal Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 700 1_
- $a Unger, Susanne $u Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Parackova, Zuzana $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic
- 700 1_
- $a Goldacker, Sigune $u Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 700 1_
- $a Sediva, Anna $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic
- 700 1_
- $a Bengsch, Bertram $u Clinic for Internal Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Signaling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany $u German Cancer Consortium (DKTK), partner site Freiburg, Freiburg, Germany
- 700 1_
- $a Warnatz, Klaus $u Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 773 0_
- $w MED00002589 $t Journal of clinical immunology $x 1573-2592 $g Roč. 42, č. 6 (2022), s. 1254-1269
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35589883 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151304 $b ABA008
- 999 __
- $a ok $b bmc $g 1891886 $s 1184686
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 42 $c 6 $d 1254-1269 $e 20220519 $i 1573-2592 $m Journal of clinical immunology $n J Clin Immunol $x MED00002589
- LZP __
- $a Pubmed-20230120